Advertisement
Subscribe now
Log in
June 03, 2026 12:16
E-Paper
E-Magazine
Corporate
CEO Talk
Biz Link
PR Newswire
Media OutReach Newswire
Investing
M&A
Outbound Investment
Investing in Haiphong
Your Consultant
KPMG
PwC
Indochine Counsel
Vilasia
Green Growth
Energy Efficiency
Rethinking Plastics
BASF
Property
Green Buildings
Industrial Properties
Money
Insurance
Smart Payment Trends
Stock Monitor
Infographics
Timeout
Travel
Hotels & Restaurants
The Insider
Entertainment
Lifestyle
Sports
Photos
Society
CSR
Swing for the Kids
World News
Tags
American Society of Clinical Oncology
Kelun-Biotech presents first-in-human data for B7-H3 ADC SKB500 at ASCO 2026
June 03, 2026 | 10:45
Sichuan Kelun-Biotech has announced that first-in-human study data for its novel B7-H3 antibody-drug conjugate SKB500 was presented at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago.
Latest News
Vietnam accelerates capital market reforms to boost foreign investor access
Reach Surgical receives CE Mark approval for SOUND REACH Swift ultrasonic shears
Markel International appoints Dan McCarthy to lead Marine, Energy and Construction division
Phihong Group unveils AI power and smart energy strategy integrating ZEROVA brand
Mobile Version